Katia Schlienger

Insider Reports History

Entity
Individual
Location
350 Fifth Avenue, 72 Nd Floor, Suite 7240, New York, NY
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Katia Schlienger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HOOKIPA Pharma Inc. Chief Medical Officer Common Stock 1.3K $943 $0.73 Mar 9, 2023 By son
HOOKIPA Pharma Inc. Chief Medical Officer Stock Option (Right to Buy) 184K Apr 14, 2023 Direct

Insider Reports Filed by Katia Schlienger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HOOK HOOKIPA Pharma Inc. Apr 14, 2023 1 $0 4 Apr 18, 2023 Chief Medical Officer
HOOK HOOKIPA Pharma Inc. Mar 9, 2023 0 $0 3 Apr 18, 2023 Chief Medical Officer